virus
evolv
alongsid
human
long
exist
filter
virus
classifi
separ
pathogen
upon
identif
infecti
diseas
character
throughout
histori
clinic
condit
caus
despit
doctor
time
idea
exist
microscop
pathogen
hippocr
father
modern
medicin
describ
sever
ill
characterist
viral
diseas
includ
influenza
poliomyel
abil
definit
identifi
specif
viru
caus
ill
becom
possibl
within
last
year
describ
chapter
world
virus
bacteria
view
light
microscop
virus
small
visual
light
microscop
consequ
first
effort
identifi
specif
virus
reli
upon
serolog
analysi
protein
antibodi
found
blood
immun
system
synthes
pathogen
tissu
cultur
abil
grow
tissu
cell
outsid
live
organ
control
environ
invent
refin
first
half
centuri
led
propag
virus
use
cell
cultur
detect
pathogen
effect
virus
exert
upon
cell
serolog
tissu
cultur
refin
still
vital
techniqu
diagnosi
viral
infect
advanc
molecular
biolog
also
acceler
abil
conclus
identifi
viru
detect
viru
caus
ill
import
mani
reason
sever
viral
infect
result
similar
clinic
symptom
virus
seriou
effect
need
identifi
earli
order
prescrib
best
treatment
likewis
infect
highrisk
group
transplant
recipi
pregnant
women
immunocompromis
individu
need
monitor
critic
sequela
address
develop
avail
antivir
drug
increas
proper
diagnosi
ensur
effect
treatment
prescrib
type
virus
also
effect
determin
subtyp
strain
virus
includ
resist
certain
drug
like
caus
cancer
field
epidemiolog
case
definit
reli
upon
laboratori
confirm
specif
viru
confirm
case
proper
diagnosi
ensur
accur
surveil
take
place
adequ
control
measur
institut
epidem
also
ensur
safeti
transplant
human
tissu
safeguard
blood
suppli
chapter
discuss
commonli
use
techniqu
detect
diagnosi
virus
clinic
sampl
mani
method
stapl
virolog
research
laboratori
well
identifi
specif
viru
type
specimen
obtain
depend
upon
type
viru
specimen
isol
locat
infect
virus
establish
local
infect
tabl
instanc
influenza
viru
readili
detect
nasopharyng
swab
herp
simplex
virus
isol
oral
genit
lesion
virus
caus
tabl
virus
establish
system
infect
may
isol
sever
differ
sourc
depend
upon
viru
site
patholog
often
good
place
start
although
viru
may
present
blood
well
exampl
hepat
b
viru
hepat
c
viru
infect
hepatocyt
liver
cell
detect
serum
choic
diagnost
test
also
depend
upon
stage
infect
person
viral
load
highest
acut
infect
may
drop
undetect
level
infect
clear
hand
take
week
antibodi
develop
primari
respons
viru
fig
describ
chapter
immun
respons
virus
igm
antibodi
isotyp
first
produc
plasma
cell
pathogen
higheraffin
igg
isotyp
begin
secret
plasma
cell
later
infect
secondari
respons
therefor
choic
diagnost
test
depend
upon
patient
stage
infect
test
viru
best
perform
symptom
present
level
igm
versu
igg
antibodi
viru
use
help
determin
infect
recent
occur
neither
present
begin
primari
infect
care
must
taken
collect
storag
transport
clinic
specimen
blood
collect
appropri
tube
depend
upon
whether
cell
serum
plasma
requir
diagnost
test
tube
contain
sodium
heparin
edta
anticoagul
block
clot
blood
use
obtain
white
blood
cell
leukocyt
plasma
liquid
fraction
remain
blood
centrifug
pellet
blood
cell
serum
obtain
allow
blood
clot
centrifug
clot
leav
behind
liquid
portion
blood
fig
differ
plasma
serum
therefor
plasma
contain
clot
factor
part
clot
serum
obtain
antibodi
virusviru
antigen
found
serum
plasma
although
viru
could
also
found
leukocyt
target
viru
collect
fluid
skin
lesion
steril
swab
use
collect
fluid
cell
lesion
open
swab
place
special
transport
medium
transport
medium
use
nasopharyng
swab
cervic
swab
rectal
swab
throat
swab
stool
collect
clean
leakproof
contain
suscept
virus
environment
factor
issu
diagnost
test
reli
upon
live
viru
mention
chapter
viru
transmiss
epidemiolog
virus
becom
noninfecti
expos
extend
period
heat
although
nucleic
acid
may
abl
recov
sampl
infecti
viru
present
prevent
viru
inactiv
sampl
blood
must
transport
diagnost
laboratori
refriger
shipment
frozen
ship
dri
ice
transport
take
day
howev
virus
stabl
frozen
includ
varicella
zoster
viru
respiratori
syncyti
viru
measl
human
cytomegaloviru
virus
must
frozen
special
transport
medium
prevent
inactiv
much
emphasi
place
upon
efficaci
diagnost
test
assay
provid
meaning
result
specimen
collect
store
transport
care
method
detect
virus
either
direct
indirect
method
direct
method
assay
presenc
viru
indirect
method
observ
effect
viru
cell
death
product
antibodi
infect
individu
tissu
cultur
way
identifi
viru
base
upon
effect
viru
upon
cell
also
way
amplifi
viru
larger
sampl
need
diagnost
test
sinc
virus
requir
cell
replic
tissu
cultur
also
known
cell
cultur
cell
grown
specif
involv
maintain
live
cell
tissu
control
environ
outsid
live
organ
cell
hous
plastic
flask
bottl
bath
liquid
growth
medium
contain
nutrient
supplement
fig
cultur
grown
incub
set
bodi
temperatur
cell
line
set
cell
isol
tissu
organ
fragment
fig
c
cell
line
finit
continu
finit
cell
line
undergo
mitosi
limit
number
time
continu
cell
line
immort
prolifer
indefinit
characterist
usual
result
genet
mutat
cell
line
deriv
tumor
lost
control
regul
cell
cycl
prolifer
indefinit
also
result
continu
cell
line
choic
finit
versu
continu
cell
line
propag
virus
cultur
depend
upon
viru
need
isol
addit
cell
line
must
one
express
cell
surfac
receptor
specif
viru
permiss
infect
otherwis
viru
abl
attach
replic
within
cell
line
cell
cultur
must
grown
use
asept
techniqu
steril
condit
otherwis
bacteria
fungi
get
cell
cultur
grow
profus
rich
growth
medium
contamin
cultur
steril
environ
provid
biolog
safeti
cabinet
bsc
differ
fume
hood
use
work
chemic
bsc
use
fan
filter
air
higheffici
particul
air
hepa
filter
filter
bacteria
fungi
spore
virus
gener
steril
air
particl
size
penetr
filter
still
remov
effici
three
differ
class
bsc
design
class
class
ii
class
iii
provid
vari
level
protect
worker
biolog
materi
manipul
class
bsc
act
much
like
chemic
fume
hood
except
air
filter
hepa
filter
releas
environ
worker
environ
protect
biolog
materi
expos
nonsteril
air
environ
use
cell
cultur
fig
class
ii
bsc
often
use
afford
protect
worker
biolog
materi
environ
air
enter
bsc
front
suck
grill
prevent
contamin
work
surfac
constantli
bath
hepafilt
air
ensur
steril
work
environ
fig
class
ii
bsc
reli
laminar
flow
air
mean
bsc
creat
uninterrupt
flow
air
consist
uninterrupt
stream
long
work
perform
within
stream
air
materi
remain
steril
air
also
sent
hepa
filter
releas
environ
class
ii
bsc
suffici
work
cell
major
virus
danger
pathogen
must
manipul
within
class
iii
bsc
airtight
prevent
exposur
viru
worker
must
use
heavyduti
rubber
glove
built
bsc
work
pathogen
fig
air
leav
class
iii
bsc
pass
two
hepa
filter
singl
hepa
filter
inciner
ensur
pathogen
enter
environ
appropri
level
safeti
must
taken
work
virus
rhinovirus
caus
cold
effect
accident
expos
rhinoviru
minim
selflimit
virus
virus
caus
hemorrhag
fever
lead
deadli
effect
someon
constitu
blood
differ
diagnost
test
requir
differ
compon
blood
tube
without
anticoagul
clot
form
centrifug
bottom
tube
acellular
liquid
fraction
serum
tube
heparin
etda
coagul
prevent
clot
factor
work
cellular
fraction
centrifug
liquid
fractionwith
clot
factorsi
known
plasma
unclot
blood
centrifug
slowli
special
medium
separ
blood
densiti
thin
white
line
leukocyt
call
buffi
coat
separ
plasma
red
blood
cell
layer
case
total
blood
plasma
erythrocyt
leukocyt
antibodi
found
serum
plasma
b
research
examin
two
blood
densiti
centrifug
note
thin
layer
leukocyt
plasma
red
blood
cell
layer
photo
courtesi
fda
michael
j
ermarth
expos
therefor
exist
four
biosafeti
level
bsl
specifi
precaut
must
taken
differ
pathogen
tabl
notabl
differ
bsl
level
summar
biosafeti
level
work
involv
wellcharacter
agent
known
caus
diseas
healthi
adult
human
pathogen
present
minim
potenti
hazard
laboratori
personnel
environ
materi
must
handl
appropri
way
decontamin
use
worker
must
use
glove
protect
along
lab
coat
safeti
glass
warrant
work
agent
requir
bsc
unless
cell
cultur
requir
use
one
maintain
steril
biosafeti
level
work
agent
known
pose
moder
hazard
personnel
andor
environ
includ
precaut
also
requir
laboratori
personnel
supervis
receiv
specif
train
handl
pathogen
agent
conduct
work
may
gener
infecti
aerosol
splash
bsc
biosafeti
level
work
could
caus
seriou
potenti
lethal
diseas
inhal
work
includ
precaut
also
requir
special
laboratori
class
bsc
protect
environ
filter
contamin
air
hepa
filter
cabinet
provid
steril
environ
within
class
bsc
mainli
use
hous
equip
might
gener
aerosol
use
steril
cultur
b
class
ii
bsc
filter
environment
air
hepa
filter
enter
cabinet
provid
steril
work
surfac
environment
air
suck
grill
open
cabinet
prevent
contamin
steril
work
area
c
class
iii
bsc
complet
seal
airtight
air
enter
exit
hood
filter
work
cabinet
must
perform
use
attach
rubber
glove
research
perform
cell
cultur
class
ii
bsc
notic
grill
front
prevent
environment
air
enter
work
area
great
major
research
clinic
laboratori
work
involv
virus
perform
class
ii
bsc
enter
two
selfclos
door
neg
pressur
contamin
air
drawn
anoth
area
hepafilt
leav
room
laboratori
personnel
must
wear
addit
protect
laboratori
cloth
gown
scrub
suit
coveral
worn
laboratori
decontamin
dispos
upon
exit
lab
work
must
perform
class
ii
class
iii
bsc
depend
upon
viru
biosafeti
level
work
danger
exot
agent
pose
high
individu
risk
aerosoltransmit
laboratori
infect
lifethreaten
diseas
frequent
fatal
vaccin
treatment
avail
addit
standard
personnel
must
chang
normal
cloth
laboratori
cloth
specif
entri
room
lab
use
laboratori
cloth
class
iii
bsc
requir
manipul
infecti
materi
must
decontamin
pass
bsc
lab
requir
use
onepiec
protect
plastic
suit
separ
air
suppli
keep
suit
posit
pressur
would
push
air
cut
tear
occur
fig
protect
suit
research
cdc
use
light
box
count
viral
plaqu
laboratori
note
suit
inflat
air
suppli
keep
posit
pressur
case
leak
suit
research
also
must
wear
laboratori
cloth
suit
scrub
case
upon
exit
lab
worker
pass
bleach
shower
decontamin
orang
plastic
suit
chang
laboratori
cloth
take
person
shower
chang
back
street
cloth
photo
taken
jame
gathani
courtesi
cdc
dr
scott
smith
suit
decontamin
bleach
shower
upon
leav
lab
either
lab
scenario
worker
must
leav
separ
exit
room
decontamin
laboratori
cloth
shower
chang
street
cloth
lab
must
separ
build
clearli
demarc
isol
zone
within
build
emerg
power
seal
environ
provid
multipl
mean
decontamin
workspac
infecti
materi
lab
reserv
danger
infecti
agent
major
diagnost
cell
cultur
take
place
gener
three
six
cell
line
select
base
upon
test
perform
cell
cultur
inocul
clinic
specimen
although
virus
seen
light
microscop
biochem
affect
cell
replic
sometim
lead
visibl
cytopath
effect
cpe
distinguish
use
light
microscop
fig
b
exampl
virus
may
caus
cell
normal
attach
bottom
cultur
vessel
round
detach
larg
bubblelik
vacuol
sometim
observ
cytoplasm
infect
cell
may
also
swell
shrink
depend
upon
viru
virus
caus
adjac
cell
membran
fuse
togeth
creat
syncytium
giant
multinucl
cell
nuclei
within
cell
virus
caus
lysi
cell
replic
virus
caus
cell
death
damag
hijack
cell
transcript
translat
machineri
leav
cell
deficit
translat
protein
includ
enzym
requir
metabol
pathway
observ
cpesand
long
take
viru
caus
themcan
provid
clue
diagnosi
viru
instanc
adenovirus
caus
cell
form
grapelik
cluster
herpesvirus
caus
cell
round
respiratori
syncyti
viru
induc
syncytia
name
suggest
time
cell
cultur
use
conjunct
assay
electron
microscopi
use
identifi
morpholog
viru
immunofluoresc
assay
ifa
immunohistochemistri
ihc
describ
detail
use
definit
identifi
specif
viru
within
cell
recogn
viral
antigen
assay
cell
grown
slide
coverslip
easi
remov
cultur
type
clinic
specimen
bypass
need
infect
cell
cultur
infect
cell
tissu
taken
directli
patient
cytolog
examin
cell
histolog
refer
examin
tissu
blood
lung
wash
cerebr
spinal
fluid
contain
cell
cell
would
also
collect
cervic
swab
brush
cell
cervix
place
liquid
preserv
relat
papanicola
pap
smear
scrape
cell
cervix
instead
smear
across
slide
sent
analysi
tzanck
smear
use
similar
idea
use
smear
cell
skin
lesion
onto
slide
diagnosi
herpesviru
infect
specimen
would
subject
cytolog
hand
tissu
collect
biopsi
taken
tissu
section
thin
slice
undergo
histolog
examin
diagnost
lab
cell
tissu
devoid
color
therefor
requir
color
stain
view
microscop
cpe
visual
infect
cell
cultur
also
seen
cell
tissu
specimen
patient
fig
anoth
type
cpe
observ
infect
cell
tissu
call
inclus
bodi
visibl
site
viral
replic
assembl
within
nucleu
cytoplasm
observ
infect
virus
fig
see
also
fig
infect
cell
cultur
cell
tissu
specimen
use
ifa
ihc
although
cell
cultur
cytolog
histolog
valuabl
provid
visibl
clue
ident
viru
virus
caus
similar
cpe
visibl
cpe
case
necessari
use
assay
detect
viral
antigen
prove
presenc
viru
accomplish
use
antibodi
recogn
specif
viral
antigen
due
advent
biotechnolog
antibodi
produc
larg
amount
commerci
avail
antibodi
recogn
differ
antigen
wide
rang
pathogen
includ
virus
sever
wide
use
rel
fast
assay
make
use
antibodi
identifi
caus
viral
infect
immuno
usual
found
name
assay
indic
use
antibodi
produc
plasma
cell
immun
system
ifa
perform
cell
tissu
affix
slide
expos
fix
cell
patient
specimen
cell
cultur
infect
patient
sampl
ifa
use
antibodi
conjug
fluorophor
fluoresc
dye
give
certain
color
excit
particular
wavelength
light
bestknown
fluoresc
dye
fluorescein
isothiocyan
better
known
fitc
excit
light
nm
blue
give
light
nm
rang
green
ifa
fitcconjug
antibodi
specif
certain
viru
ad
liquid
buffer
onto
cell
tissu
slide
fig
viral
antigen
recogn
antibodi
present
cell
surfac
perhap
viru
assembl
plasma
membran
process
infect
cell
section
fix
antibodi
bind
viral
antigen
present
altern
cell
permeabil
deterg
allow
antibodi
enter
insid
plasma
membran
bind
viral
antigen
fig
either
case
antibodi
bind
specif
antigen
present
suffici
period
time
allow
bind
fitclabel
antibodi
slide
wash
buffer
antibodi
bound
remain
bound
wherea
unbound
antibodi
rins
slide
examin
fluoresc
microscop
contain
special
lightbulb
provid
wavelength
light
abl
excit
fluorophor
filter
allow
viewer
see
one
emit
color
time
case
green
cell
seen
antibodi
bound
viru
present
antibodi
directli
bound
specif
antibodi
ifa
known
direct
ifa
direct
fluoresc
antibodi
stain
howev
sometim
conjug
antibodi
avail
case
second
antibodi
must
use
fluoresc
conjug
recogn
primari
antibodi
fig
way
get
around
conjug
primari
antibodi
also
use
amplifi
weak
signal
much
viral
antigen
present
assay
requir
secondari
antibodi
fluorochrom
attach
primari
antibodi
known
indirect
ifa
ifa
use
identif
varieti
virus
includ
sever
differ
herpesvirus
influenza
measl
mump
adenoviru
fig
ihc
reli
upon
principl
ifa
except
antibodi
conjug
enzym
instead
fluoresc
molecul
tissu
expos
enzymebound
primari
antibodi
liquid
substrat
ad
slide
enzymelink
antibodi
bound
tissu
enzym
cleav
substrat
visibl
color
precipit
deposit
slide
ihc
visibl
use
normal
light
microscop
requir
use
fluoresc
microscop
ifa
ihc
take
littl
hour
perform
figur
immunofluoresc
immunofluoresc
use
virusspecif
antibodi
verifi
infect
buffer
contain
fitcconjug
antibodi
ad
fix
cell
tissu
cell
cultur
celltissu
specimen
antibodi
bind
cognat
viral
antigen
express
surfac
infect
cell
prevent
rins
slide
incub
stain
cell
examin
fluoresc
microscop
excit
fitc
dye
fluoresc
green
process
also
use
detect
intracellular
antigen
permeabil
plasma
membran
allow
antibodi
enter
cell
b
antibodi
commerci
avail
alreadi
conjug
fitclabel
secondari
antibodi
recogn
first
antibodi
must
use
c
exampl
ifa
perform
cell
verifi
presenc
respiratori
syncyti
viru
green
cell
therefor
infect
photo
courtesi
cdc
dr
craig
lyerla
extens
concept
take
place
enzym
immunoassay
eia
also
known
enzymelink
immunosorb
assay
elisa
like
ifa
ihc
eia
elisa
also
detect
viral
antigen
use
antigenspecif
antibodi
unlik
ifa
ihc
howev
use
cell
tissu
instead
assay
viral
antigen
liquid
sampl
serum
urin
sandwich
elisa
start
ad
antibodi
buffer
special
plastic
plate
treat
bind
proteinsinclud
antibodiesto
fig
known
captur
antibodi
use
captur
antigen
patient
sampl
antibodi
bound
well
plateusu
themar
rins
buffer
remov
unbound
antibodi
plate
block
mean
buffer
ad
contain
nonspecif
protein
attach
plastic
well
wherev
antibodi
bound
well
rins
patient
sampl
ad
antigen
present
sampl
either
viru
piec
viru
present
antigen
bind
captur
antibodi
contrast
viral
antigen
present
patient
sampl
captur
antibodi
captur
antigen
well
rins
remov
leftov
patient
sampl
next
antibodi
ad
conjug
enzym
ihc
enzymelink
part
elisa
name
deriv
immunosorb
part
indic
antibodi
immuno
part
absorb
antigen
enzymelink
antibodi
call
detect
antibodi
also
specif
recogn
antigen
creat
sandwich
antibodi
bread
antigen
meathenc
name
sandwich
elisa
suffici
time
bind
occur
well
rins
detect
antibodi
remain
bound
plate
antigen
present
antigen
bound
captur
antibodi
noth
detect
antibodi
bind
rins
well
final
step
add
liquid
enzym
substrat
detect
antibodi
presentmean
captur
antibodi
bound
antigen
antigen
present
patient
samplethen
enzym
attach
detect
antibodi
cleav
substrat
produc
visibl
color
well
antigen
present
detect
antibodi
catalyz
substrat
reaction
color
occur
spectrophotomet
measur
intens
light
includ
color
light
special
spectrophotomet
fig
measur
color
well
provid
optic
densiti
valu
indic
rel
amount
antigen
present
well
standard
set
sampl
known
concentr
also
test
elisa
plate
valu
obtain
patient
sampl
compar
standard
obtain
quantit
valu
posit
neg
control
alway
perform
elisa
verifi
assay
perform
correctli
step
elisa
usual
allow
around
hour
two
bind
occur
therefor
elisa
take
sever
hour
perform
togeth
result
usual
avail
day
clinic
specimen
receiv
test
hepat
b
surfac
antigen
perform
use
sandwich
elisa
elisa
use
detect
viral
antigen
determin
presenc
antibodi
viru
known
antivir
antibodi
assay
antivir
antibodi
indirect
way
see
patient
expos
viru
elisa
differenti
igm
igg
provid
clue
whether
patient
newli
expos
person
igm
becom
posit
igg
cours
day
person
experienc
primari
infect
person
high
level
igg
secondari
recurr
infect
antibodi
isotyp
also
use
diagnos
congenit
infect
igg
cross
placenta
mother
child
therefor
help
diagnosi
igm
larg
cross
placenta
therefor
igm
present
infant
blood
made
infant
immun
system
indic
infect
child
assay
antibodi
viral
antigen
coat
onto
bottom
elisa
plate
fig
patient
sampl
ad
patient
possess
antibodi
recogn
viral
antigen
antibodi
attach
antigen
plate
therebi
immobil
antibodi
plate
well
sandwich
elisa
next
step
addit
enzymelink
detect
antibodi
case
detect
antibodi
recogn
patient
antibodi
final
well
rins
substrat
ad
patient
possess
antibodi
viral
antigen
patient
antibodi
subsequ
detect
antibodi
would
bound
antigen
coat
well
presenc
enzym
would
cleav
substrat
produc
color
fig
western
blot
util
similar
process
except
protein
antigen
immobil
gel
first
way
dna
separ
use
agaros
gel
electrophoresi
protein
separ
size
use
polyacrylamid
gel
electrophoresi
page
fig
protein
embed
polyacrylamid
gel
transfer
onto
membran
made
nitrocellulos
point
membran
function
like
well
elisa
plate
enzymelink
antibodi
protein
separ
ad
liquid
buffer
membran
bind
specif
band
protein
antigen
fig
substrat
ad
enzym
present
produc
detect
color
light
fluoresc
depend
upon
enzym
substrat
use
fig
western
blot
often
use
confirm
posit
elisa
result
exampl
person
take
oral
hiv
test
use
saliva
receiv
posit
result
test
must
confirm
use
western
blot
scenario
hiv
antigen
separ
page
transfer
figur
enzymelink
immunosorb
assay
elisa
elisa
measur
viral
antigen
direct
sandwich
elisa
antivir
antibodi
indirect
elisa
sandwich
elisa
left
captur
antibodi
specif
viral
antigen
coat
bottom
well
block
prevent
nonspecif
bind
well
rins
step
remov
unbound
molecul
patient
sampl
ad
one
sampl
per
well
point
cognat
viral
antigen
bound
captur
antibodi
next
enzymelink
detect
antibodi
ad
well
also
bind
viral
antigen
present
substrat
ad
cleav
enzym
present
form
visibl
color
read
spectrophotomet
indirect
elisa
right
viral
antigen
coat
bottom
well
block
patient
sampl
ad
patient
antibodi
recogn
viral
antigen
bind
plate
well
secondari
enzymelink
antibodi
ad
recogn
human
antibodi
enzym
cleav
substrat
ad
produc
color
nitrocellulos
membran
expos
patient
serum
patient
antihiv
antibodi
bind
onto
membran
hiv
antigen
found
secondari
enzymelink
antibodi
provid
enzym
caus
color
band
produc
expos
substrat
western
blot
still
recommend
confirm
oral
hiv
test
although
nucleic
acid
test
choic
confirmatori
test
posit
hiv
blood
test
agglutin
reaction
take
place
bind
antibodi
antigen
caus
visibl
clump
agglutin
latex
agglutin
test
use
principl
elisa
western
blot
except
antigen
antibodi
bound
onto
small
latex
bead
fig
test
patient
antibodi
viral
antigen
coat
onto
latex
bead
mix
patient
serum
antibodi
bind
antigenco
latex
bead
antibodi
two
antigenbind
site
arm
antibodi
abl
bind
differ
bead
result
bead
splay
lattic
formationth
bead
agglutin
visibl
clump
form
patient
antibodi
particular
viral
antigen
latex
bead
agglutin
agglutin
reaction
take
place
tube
plate
slide
use
cardboard
card
like
elisa
latex
agglutin
test
patient
serum
sampl
incub
membran
patient
antihiv
antibodi
bind
hiv
protein
membran
enzymelink
secondari
antibodi
ad
recogn
human
antibodi
enzym
part
shown
save
room
substrat
ad
produc
detect
signal
case
substrat
give
light
creat
dark
mark
place
xray
film
c
scenario
patient
posit
antihiv
antibodi
thu
infect
hiv
also
test
viral
antigen
patient
sampl
coat
antibodi
onto
bead
recogn
antigen
sever
antibodyco
bead
bind
one
antigen
result
visibl
agglutin
hemagglutin
refer
agglutin
red
blood
cell
hand
virus
includ
influenza
viru
measl
viru
mump
viru
rubella
viru
rabi
viru
caus
hemagglutin
red
blood
cell
viral
attach
glycoprotein
aptli
name
hemagglutinin
influenza
measl
mump
virus
bind
surfac
red
blood
cell
agglutin
similarli
antibodi
fig
c
hemagglutin
assay
use
show
presenc
virus
sampl
similar
assay
test
antibodi
level
patient
sampl
one
virus
fix
amount
viru
ad
well
patient
serum
titrat
well
differ
dilut
patient
antibodi
viru
antibodi
bind
viru
prevent
hemagglutin
red
blood
cell
use
dilut
patient
serum
rel
amount
antibodi
determin
note
dilut
prevent
hemagglutin
assay
use
antibodi
similar
fashion
assay
describ
call
later
flow
immunoassay
lfia
case
presenc
viru
antibodi
viru
test
assay
antivir
antibodi
result
color
band
appear
particular
window
test
pregnanc
test
bestknown
lfia
lfia
avail
test
hiv
antibodi
dengu
viru
antibodi
rotaviru
respiratori
syncyti
viru
influenza
viru
form
dipstick
like
pregnanc
test
small
plastic
test
requir
drop
sampl
place
sampl
well
fig
lfia
test
reagent
ad
onto
nitrocellulos
membran
draw
liquid
along
length
strip
use
capillari
action
fig
test
strip
contain
three
major
zone
reaction
zone
test
zone
control
zone
case
influenza
lfia
patient
specimen
usual
nasal
nasopharyng
swab
mix
buffer
disrupt
virion
present
releas
viral
antigen
drop
liquid
sampl
place
sampl
well
one
end
lfia
test
viral
antigen
begin
move
membran
capillari
action
reaction
zone
test
reaction
zone
contain
free
antibodi
bound
gold
bead
blue
latex
bead
basi
format
color
later
test
viral
antigen
pass
reaction
zone
beadlink
antibodi
bind
antigen
antigenbead
complex
continu
move
membran
test
zone
next
zone
encount
test
zone
antibodi
immobil
membran
recogn
viral
antigen
bound
reaction
zone
beadlink
antibodi
bind
antigenbead
complex
test
zone
antibodi
immobil
antigenbead
complex
test
zone
area
creat
antigen
sandwich
bead
begin
accumul
color
figur
agglutinationhemagglutin
latex
agglutin
assay
coat
viral
antigen
onto
latex
bead
antibodi
present
recogn
antigen
agglutin
bead
procedur
perform
assay
presenc
viral
antigen
coat
antibodi
bead
b
hemagglutin
refer
agglutin
red
blood
cell
specif
sever
virus
includ
influenza
viru
measl
viru
possess
hemagglutinin
protein
bind
red
blood
cell
surfac
glycoprotein
hemagglutin
use
identifi
virus
c
result
hemagglutin
reaction
show
hemagglutin
occur
increas
amount
viru
titrat
well
button
left
clump
right
show
visibl
chang
occur
hemagglutin
blood
right
imag
courtesi
liu
et
al
polylacnac
agespecif
ligand
rotaviru
p
neonat
infant
plo
one
patient
sampl
ad
sampl
well
assay
begin
move
though
membran
via
capillari
action
reaction
zone
antigen
found
patient
sampl
bind
free
antibodyco
bead
beadantigen
complex
continu
travel
test
zone
membranebound
antibodi
bind
antigen
therebi
immobil
bead
bead
accumul
color
line
form
excess
bead
complex
continu
move
membran
eventu
bound
control
zone
antibodi
recogn
bead
complex
rather
antigen
excess
bead
accumul
color
control
line
form
b
lfia
use
diagnosi
viral
infect
anim
well
lfia
test
two
felin
virus
felin
immunodefici
viru
felin
leukemia
viru
note
control
spot
present
color
spot
test
zone
area
indic
anim
neg
virus
bead
becom
appar
blue
latex
bead
provid
blue
band
gold
bead
appear
red
band
indic
posit
resultthat
person
specimen
contain
viru
final
zone
control
zone
contain
antibodi
bind
bead
complex
reaction
zone
bead
bound
antigen
continu
flow
test
zone
captur
control
zone
antibodi
fact
mani
reaction
zone
bead
antigen
bead
free
even
presenc
antigen
make
control
zone
captur
bead
control
zone
produc
visibl
line
section
test
posit
control
show
test
work
hiv
dengu
viru
lfia
use
principl
except
assay
presenc
antibodi
virus
rather
detect
virus
nucleic
acid
test
nat
replac
mani
tradit
slower
assay
diagnost
lab
detect
viral
nucleic
acid
sensit
specif
way
screen
virus
within
patient
sampl
new
method
allow
screen
mani
virus
simultan
addit
nat
abl
detect
presenc
virus
test
current
exist
nat
result
avail
day
sampl
process
nat
assay
reli
upon
principl
polymeras
chain
reaction
pcr
recapitul
process
dna
replic
laboratori
provid
molecul
necessari
copi
dna
see
chapter
featur
host
cell
cellular
molecular
biolog
review
review
process
pcr
dna
includ
viral
dna
present
isol
clinic
specimen
gener
blood
cell
tissu
ad
tube
contain
primer
dna
polymeras
nucleotid
fig
tube
place
thermocycl
benchtop
machin
simpli
chang
temperatur
tube
name
suggest
denatur
stage
pcr
thermocycl
heat
dna
usual
break
hydrogen
bond
hold
two
dna
strand
togeth
separ
anneal
stage
temperatur
reduc
allow
bind
anneal
two
primer
separ
dna
primer
complementari
sequenc
bind
flank
region
amplifi
one
primer
strand
anneal
temperatur
determin
composit
nucleotid
primer
usual
around
final
stage
extens
thermocycl
rais
temperatur
optim
temperatur
dna
polymeras
enzym
case
special
polymeras
bacterium
thermu
aquaticu
call
taq
polymeras
use
thermu
aquaticu
discov
live
hot
spring
yellowston
nation
park
dna
polymeras
evolv
withstand
high
temperatur
found
hot
spring
taq
polymeras
use
pcr
human
dna
polymeras
would
denatur
high
temperatur
requir
denatur
stage
thermocycl
hold
temperatur
taq
polymeras
extend
often
necessari
know
mani
infecti
virion
present
sampl
diagnost
techniqu
describ
chapter
identifi
presenc
viru
sampl
even
amount
viral
nucleic
acid
assay
determin
amount
viru
present
capabl
product
infect
cell
common
virolog
techniqu
determin
known
plaqu
assay
measur
number
virion
sampl
abl
initi
infect
target
cell
microbiologist
measur
viabl
bacteria
determin
number
individu
bacteri
cell
sampl
form
distinct
bacteri
coloni
result
number
colonyform
unit
cfu
sampl
plaqu
assay
measur
number
individu
cell
infect
singl
virion
form
plaqu
clear
viru
spread
among
neighbor
cell
result
number
plaqueform
unit
pfu
sampl
indic
viral
infect
perform
plaqu
assay
first
step
use
cell
cultur
plate
cell
sever
cell
cultur
dish
multiwel
plate
often
use
purposein
liquid
medium
support
growth
fig
cell
line
use
must
permiss
infect
viru
studi
cell
allow
grow
near
confluenc
mean
grown
complet
cover
bottom
cell
cultur
vessel
point
medium
remov
well
tenfold
serial
dilut
initi
sampl
made
case
initi
sampl
much
infecti
viru
end
harm
entir
well
cell
ml
experiment
sampl
ad
individu
well
plate
cell
gentli
shaken
flat
surfac
move
plate
motion
plu
sign
ensur
viru
ad
equal
distribut
cell
viru
given
time
bind
enter
cell
h
point
cell
cover
layer
cool
agaros
mix
medium
enter
random
cell
well
viru
replic
cours
follow
day
agaros
ensur
releas
virion
abl
infect
cell
immedi
adjac
infect
cell
viru
replic
infect
cell
begin
form
plaqu
clear
caus
cytopath
effect
upon
cluster
infect
cell
case
viru
lyse
infect
cell
case
viru
interf
enough
cellular
process
caus
damag
death
infect
cell
eukaryot
virus
typic
take
day
form
plaqu
larg
enough
see
cell
clear
dye
use
stain
live
cell
leav
clear
plaqu
visibl
well
inspect
number
plaqu
count
give
number
pfu
per
well
howev
need
convert
pfuml
origin
sampl
number
plaqu
must
divid
dilut
sampl
ml
sinc
amount
ad
cell
therefor
ml
dilut
result
plaqu
mean
start
sampl
pfuml
initi
best
write
use
scientif
notat
amount
infecti
viru
start
sampl
pfuml
figur
plaqu
assay
determin
amount
infecti
viru
sampl
plaqu
assay
perform
varieti
differ
type
cultur
vessel
depend
upon
size
plaqu
form
shown
tissu
cultur
dish
plate
plate
b
perform
plaqu
assay
undilut
neat
sampl
dilut
sever
time
use
dilut
ml
dilut
ad
individu
dish
cell
allow
time
viru
enter
cell
h
layer
agaros
use
overlay
cell
ensur
later
infect
infect
cell
depend
viru
gener
take
day
visibl
site
replic
call
plaqu
visibl
point
live
cell
stain
clear
count
see
fig
dilut
multipl
distinct
plaqu
chosen
determin
pfuml
origin
sampl
case
undilut
sampl
pfuml
primer
use
avail
nucleotid
creat
doublestrand
piec
dna
singlestrand
templat
way
one
doublestrand
piec
dna
separ
replic
creat
two
copi
stage
pcr
repeat
usual
time
creat
billion
copi
target
dna
segment
case
viral
diagnosi
primer
would
specif
piec
viral
genom
good
primer
bind
viral
dna
amplifi
isol
cellular
dna
genom
virus
virus
rna
genom
case
revers
transcriptas
pcr
rtpcr
carri
involv
step
perform
pcr
viral
genom
rna
must
revers
transcrib
cdna
first
accomplish
use
revers
transcriptas
transcrib
cdna
rna
genom
revers
transcriptas
use
rtpcr
deriv
retrovirus
gener
moloney
murin
leukemia
viru
avian
myeloblastosi
viru
addit
step
creat
cdna
amplifi
use
pcr
amplifi
dna
fragment
known
amplicon
detect
sever
differ
way
agaros
gel
electrophoresi
remain
simplest
cheapest
method
agaros
gel
electrophoresi
use
electr
separ
dna
fragment
agaros
gel
distanc
travel
dna
base
upon
fragment
size
smaller
fragment
travel
farther
gel
larger
fragment
separ
complet
gel
stain
chemic
known
ethidium
bromid
intercal
base
pair
dna
fluoresc
expos
uv
light
fluoresc
band
therefor
indic
dna
present
amplifi
pcr
reaction
smaller
fragment
travel
farther
gel
rel
locat
band
verifi
band
produc
anticip
size
compar
known
dna
ladder
multiplex
pcr
allow
amplif
sever
differ
piec
dna
time
tube
techniqu
involv
process
normal
pcr
rtpcr
multipl
primer
pair
ad
reaction
tube
primer
pair
design
recogn
nucleic
acid
distinct
viru
size
amplicon
produc
differ
viru
allow
simultan
amplif
dna
sever
virus
one
time
analyz
size
amplicon
reveal
virus
present
initi
start
sampl
pcr
invent
kari
mulli
molecular
biolog
techniqu
built
upon
adapt
produc
numer
assay
great
util
modif
pcr
ubiquit
use
known
realtim
pcr
name
user
monitor
amplicon
amplif
real
time
use
special
thermocycl
great
advantag
monitor
reaction
proce
rate
amplif
note
tradit
pcr
machin
analyz
product
complet
cycl
make
imposs
know
reaction
plateau
earlier
cycl
limit
reagent
nucleotid
realtim
pcr
machin
address
concern
provid
visual
graph
amplif
advantag
abl
see
amplif
real
time
quantiti
pcr
product
use
back
calcul
amount
start
templat
nucleic
acid
present
sinc
know
cycl
doubl
amount
dna
reason
realtim
pcr
also
known
quantit
pcr
therefor
standard
abbrevi
realtim
pcr
qpcr
recal
rtpcr
stand
revers
transcriptas
pcr
realtim
pcr
rtpcr
also
perform
use
qpcr
techniqu
known
rtqpcr
dna
amplif
monitor
real
time
qpcr
two
major
method
involv
use
fluoresc
first
method
fluoresc
dye
use
intercal
doublestrand
dna
way
ethidium
bromid
exampl
fluoresc
dnabind
dye
sybr
green
excit
light
nm
emit
light
nm
green
realtim
thermocycl
abl
provid
excit
wavelength
detector
measur
emit
wavelength
anoth
method
involv
fluoresc
report
probe
taqman
probe
fig
like
primer
probe
recogn
sequenc
dna
target
locat
middl
amplifi
sequenc
primer
attach
probe
fluoresc
report
dye
one
end
quencher
long
report
dye
quencher
attach
probe
quencher
absorb
fluoresc
emit
excit
report
dye
process
fluoresc
reson
energi
transfer
fret
taq
polymeras
break
nucleotid
probe
amplifi
dna
probe
bound
releas
report
dye
quencher
probe
occur
two
physic
separ
quencher
molecul
longer
inhibit
report
fluoresc
fluoresc
doublestrand
dna
dye
report
dye
excit
detect
thermocycl
use
either
method
increas
fluoresc
indic
increas
amplifi
product
dna
amplif
plot
creat
measur
fluoresc
taken
real
time
fig
allow
dna
product
quantifi
cycl
number
amplif
exponenti
phase
use
back
calcul
amount
start
templat
dna
multiplex
qpcr
assay
also
develop
allow
simultan
detect
sever
fluoresc
probe
one
tube
one
amplifi
viral
dna
segment
pcr
qpcr
amplifi
specif
sequenc
viral
dna
hand
dna
microarray
reli
upon
hybrid
viral
nucleic
acid
segment
synthes
piec
dna
hybrid
refer
complementari
bind
two
nucleic
acid
piec
instanc
primer
hybrid
target
dna
pcr
dna
microarray
thousand
short
singlestrand
piec
dna
call
oligonucleotid
oligo
immobil
onto
small
silicon
chip
glass
slide
fig
oligo
like
primer
abl
synthes
laboratori
use
special
piec
equip
bond
individu
nucleotid
togeth
strand
nucleic
acid
detect
presenc
viral
nucleic
acid
sequenc
synthes
oligo
probe
spot
chip
complementari
known
sequenc
within
viral
genom
interest
sinc
viral
nucleic
acid
may
low
abund
sampl
microarray
experi
begin
pcr
amplifi
sampl
dna
fig
primer
use
amplifi
randomli
rather
specif
dna
sampl
amplifi
fluoresc
nucleotid
incorpor
amplifi
dna
follow
amplif
fluoresc
dna
ad
microarray
hybrid
allow
occur
sampl
dna
oligo
microarray
hybrid
dna
remain
bound
oligo
chip
unhybrid
dna
rins
away
microarray
read
machin
measur
fluoresc
fluoresc
present
particular
oligo
spot
dna
sampl
bound
machin
report
posit
result
fig
ident
oligo
known
sequenc
present
initi
dna
sampl
determin
realtim
pcr
work
principl
pcr
except
measur
fluoresc
report
dye
real
time
monitor
amplif
reaction
dnabind
dye
use
probe
attach
report
dye
quencher
molecul
probe
hybrid
section
target
dna
two
primer
long
report
quencher
physic
close
quencher
absorb
fluoresc
none
given
primer
extend
dna
polymeras
probe
broken
releas
report
dye
quencher
free
quencher
report
dye
fluoresc
fluoresc
increas
cycl
repeat
b
realtim
pcr
amplif
plot
show
amplif
eight
differ
concentr
jc
polyomaviru
jcpyv
dna
number
reaction
cycl
x
axi
fluoresc
gener
reaction
axi
import
thing
note
sampl
start
dna
amplifi
quickli
requir
fewer
cycl
reach
set
threshold
also
cycl
eventu
plateau
around
fluoresc
even
though
know
sampl
contain
dna
other
sampl
compar
threshold
limit
green
line
multiplex
qpcr
black
line
amplif
jcpyv
proteincod
genom
sequenc
red
line
amplif
noncod
genom
region
amplif
plot
reprint
ryschkewitsch
cf
et
al
microarray
use
viru
identif
modifi
oligo
chip
microarray
also
identifi
strain
virus
particularli
virul
genet
resist
certain
therapeut
long
genom
sequenc
known
correspond
attribut
oligo
made
correspond
genet
trait
microarray
principl
employ
identif
rna
transcript
protein
well
exampl
instead
use
dna
oligo
captur
nucleic
acid
protein
microarray
use
antibodi
captur
differ
protein
excit
applic
dna
microarray
virochip
develop
derisi
ganem
laboratori
univers
california
san
francisco
virochip
use
long
oligo
probe
complementari
known
viral
sequenc
virochip
contain
probe
detect
virus
research
includ
oligo
conserv
novel
sequenc
found
relat
virus
way
virochip
identifi
similar
virus
base
upon
conserv
genom
region
also
identifi
individu
subtyp
strain
base
upon
novel
nucleotid
sequenc
possess
relat
virus
virochip
also
use
character
novel
virus
exampl
use
assist
cdc
identifi
novel
viru
caus
death
southeast
asia
microarray
suggest
unknown
viru
previous
unrecogn
coronaviru
later
known
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
creat
oligo
probe
use
virochip
research
use
genom
sequenc
virus
sequenc
highthroughput
sequenc
method
allow
determin
nucleotid
sequenc
potenti
biolog
entiti
includ
virus
earlier
day
viral
diagnosi
cpe
use
classifi
differ
subtyp
genotyp
virus
replac
serolog
use
antibodi
determin
viral
subtyp
sequenc
viral
genom
provid
definit
differenti
nucleic
acid
level
current
viral
genom
complet
sequenc
public
databas
exist
genom
hiv
influenza
virus
dengu
viru
hepat
c
viru
among
other
sequenc
also
allow
us
track
genet
differ
relat
subtyp
strain
virus
assist
scientist
identifi
novel
virus
compar
genom
sequenc
known
virus
bioinformat
field
studi
use
comput
analyz
compar
biolog
data
includ
genom
protein
sequenc
bioinformat
use
compar
viral
genom
sequenc
monitor
viral
evolut
time
track
viru
mutat
appear
epidem
advantag
disadvantag
everi
method
diagnosi
tabl
rang
test
avail
diagnosi
confirm
commonli
encount
viral
infect
tabl
microarray
like
virochip
identifi
virus
within
sampl
start
dna
copi
use
pcr
fluoresc
nucleotid
incorpor
process
fluoresc
amplicon
ad
microarray
spot
thousand
differ
oligonucleotid
probe
recogn
differ
viral
sequenc
hybrid
occur
sampl
dna
viru
nucleic
acid
present
start
sampl
machin
measur
fluoresc
spot
b
exampl
microarray
found
blue
chip
middl
photo
note
size
chip
compar
size
research
thumb
chip
contain
probe
hybrid
singl
nucleotid
differ
within
human
genom
c
small
portion
oligo
spot
actual
readout
chip
show
spot
fluoresc
present
result
use
two
differ
sampl
cdna
one
label
green
one
label
red
l
specimen
collect
varieti
bodi
fluid
choic
specimen
depend
upon
site
stage
infect
whether
best
test
viru
antivir
antibodi
